News

News about advances made possible through IPIRA's work, such as innovations commercialized, campus partnerships with industry, and companies born out of licensing UC Berkeley intellectual property rights.

All News

March 20, 2023

Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479

March 10, 2023

March 7, 2023

January 9, 2023

December 20, 2022

November 12, 2022

November 8, 2022

November 1, 2022

October 19, 2022

October 5, 2022

September 27, 2022

September 14, 2022

September 4, 2022

August 23, 2022

July 28, 2022

July 27, 2022

July 25, 2022

July 15, 2022

July 1, 2022